About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Early Dehiscence Markers in Ovarian Cancer Surgery

NCT03131492·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Hospital Universitari Vall d'Hebron Research Institute

Age

18–any

Sex

FEMALE

Healthy volunteers

Not accepted

You may be eligible if

Ovarian cancer stage III-IV
Intestinal resection needed

You may not be if

Infection diagnosed at time of surgery.
Urgent surgery

The record

StatusCompleted

PhaseNo phase

Taking part92

StartedMar 2017

UpdatedSep 29, 2022

Conditions

Ovarian Neoplasms Malignant Anastomotic Leak

Where1

Hospital Universitari de la Vall d'Hebron
Barcelona, Spain

Clareo Health | Early Dehiscence Markers in Ovarian Cancer Surgery